Peak Pharma Balance Sheet - Annual (OTCMKTS:PKPH)

Add to My Stocks
$0.13 $0 (0%) PKPH stock closing price Sep 21, 2018 (Closing)

The financial analysis of a company involves interpreting the income statement, balance sheet and cash flow statements of the company to draw insights like we've done in our Peak Pharma stock analysis. Balance sheet items like cash at hand, total assets and liabilities helps one analyze a company and summarize the financial performance of the company like we have in our Peak Pharma stock analysis. Good annual results indicate a company's strong financial performance. Its important to check all financial statements including the balance sheet. The balance sheet shows total liabilities of $- and shareholders equity of $-0.19M. Peak Pharma revenue and Peak Pharma operating cash flow are important in understanding the financial capacity of the company.

View latest 10 year balance sheet data to check Peak Pharma financial performance.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Oct - Sep2017201620152014201320122011201020092008
Cash----------
Marketable Securities----------
Receivables----------
Inventory----------
Raw Materials----------
Work In Progress----------
Finished Goods----------
Notes Receivable----------
Other Current Assets----------
Total Current Assets
----------
Property Plant & Equipment----------
Accumulated Depreciation----------
Net Property Plant & Equipment
----------
Investment & Advances----------
Other Non-Current Assets----------
Deferred Charges----------
Intangibles----------
Deposits & Other Assets----------
Total Assets
----------
Notes Payable----------
Accounts Payable----------
Current Portion Long-Term Debt----------
Current Portion Capital Leases----------
Accrued Expenses----------
Income Taxes Payable----------
Other Current Liabilities----------
Total Current Liabilities
----------
Mortgages----------
Deferred Taxes/Income----------
Convertible Debt----------
Long-Term Debt----------
Non-Current Capital Leases----------
Other Long-Term Liabilities----------
Total Liabilities
----------
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus4.85M4.85M6.15M4.28M------
Retained Earnings-5.05M-5M-6.16M-3.85M-0.1M-0.08M-0.06M-0.05M-0.02M-0.01M
Treasury Stock----------
Other Liabilities----------
Shareholders Equity-0.19M-0.14M-0.01M--0.03M-0.02M-0.01M---
Total Liabilities & Shareholders Equity----------
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Most investors just check the Peak Pharma stock price, and Peak Pharma historical stock prices before investing. While share price is an important factor, one should also look at financials and valuation metrics like the Peak Pharma PE ratio chart. Below is a brief explanation of common balance sheet terms:

  • Assets: An asset is a resource that a corporation like Peak Pharma owns and has economic value. The two major types of assets are: fixed assets like real estate, plant and machinery and current assets like cash, marketable securities and inventory. The total asset value for PKPH stock as of 2017 is $-. Its easy to associate the term with manufacturing companies, which invest a lot in factories and equipment. However, the same cannot be said about tech stocks.
  • Liabilities: The total liabilities of Peak Pharma for the year 2017 total to $-. Liabilities for a company like Peak Pharma include bank loans, services which have been availed for which a settlement in the form of cash/ asset transfer needs to be done in future etc. A firm takes on such obligations to grow its business which in turn will generate future economic benefits for its business.

Peak Pharma Balance Sheet - Key Ratios

Annual Balance Sheets For Peak Pharmaceuticals Inc Peers

GelStat balance sheet, MYOS RENS balance sheet, Protalex balance sheet